229 related articles for article (PubMed ID: 26794822)
1. [Phosphorus: a new cardiovascular risk factor?].
Insalaco M; Scuderi R; Zanoli L; Galeano D; Failla A; Fatuzzo P; Granata A
Clin Ter; 2015; 166(6):e389-400. PubMed ID: 26794822
[TBL] [Abstract][Full Text] [Related]
2. Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.
Molony DA; Stephens BW
Adv Chronic Kidney Dis; 2011 Mar; 18(2):120-31. PubMed ID: 21406297
[TBL] [Abstract][Full Text] [Related]
3. Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study.
Lioufas N; Toussaint ND; Pedagogos E; Elder G; Badve SV; Pascoe E; Valks A; Hawley C;
BMJ Open; 2019 Feb; 9(2):e024382. PubMed ID: 30796122
[TBL] [Abstract][Full Text] [Related]
4. FGF23: a mature renal and cardiovascular risk factor?
Zoccali C; Yilmaz MI; Mallamaci F
Blood Purif; 2013; 36(1):52-7. PubMed ID: 23735695
[TBL] [Abstract][Full Text] [Related]
5. Use of phosphate binders in chronic kidney disease.
Ketteler M; Biggar PH
Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):413-20. PubMed ID: 23736841
[TBL] [Abstract][Full Text] [Related]
6. Phosphate Toxicity in CKD: The Killer among Us.
Ritter CS; Slatopolsky E
Clin J Am Soc Nephrol; 2016 Jun; 11(6):1088-1100. PubMed ID: 26912542
[TBL] [Abstract][Full Text] [Related]
7. Niacin and Chronic Kidney Disease.
Taketani Y; Masuda M; Yamanaka-Okumura H; Tatsumi S; Segawa H; Miyamoto K; Takeda E; Yamamoto H
J Nutr Sci Vitaminol (Tokyo); 2015; 61 Suppl():S173-5. PubMed ID: 26598845
[TBL] [Abstract][Full Text] [Related]
8. Dietary phosphorus and kidney disease.
Uribarri J
Ann N Y Acad Sci; 2013 Oct; 1301():11-9. PubMed ID: 23876096
[TBL] [Abstract][Full Text] [Related]
9. Phosphate: a stealthier killer than previously thought?
Gonzalez-Parra E; Tuñón J; Egido J; Ortiz A
Cardiovasc Pathol; 2012; 21(5):372-81. PubMed ID: 22425627
[TBL] [Abstract][Full Text] [Related]
10. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
11. Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease.
Houston J; Smith K; Isakova T; Sowden N; Wolf M; Gutiérrez OM
J Ren Nutr; 2013 Jan; 23(1):12-20. PubMed ID: 22406119
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota; an overlooked effect of phosphate binders.
Rahbar Saadat Y; Niknafs B; Hosseiniyan Khatibi SM; Ardalan M; Majdi H; Bahmanpoor Z; Abediazar S; Zununi Vahed S
Eur J Pharmacol; 2020 Feb; 868():172892. PubMed ID: 31870830
[TBL] [Abstract][Full Text] [Related]
13. Control of metabolic predisposition to cardiovascular complications of chronic kidney disease by effervescent calcium magnesium citrate: a feasibility study.
Quiñones H; Hamdi T; Sakhaee K; Pasch A; Moe OW; Pak CYC
J Nephrol; 2019 Feb; 32(1):93-100. PubMed ID: 30465137
[TBL] [Abstract][Full Text] [Related]
14. Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
Navaneethan SD; Palmer SC; Craig JC; Elder GJ; Strippoli GF
Am J Kidney Dis; 2009 Oct; 54(4):619-37. PubMed ID: 19692157
[TBL] [Abstract][Full Text] [Related]
15. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
[TBL] [Abstract][Full Text] [Related]
16. Phosphate binders in moderate chronic kidney disease: where do we stand?
Bellasi A; Cozzolino M; Adragao T; Di Iorio B; Russo D
J Nephrol; 2013; 26(6):993-1000. PubMed ID: 23543481
[TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment of hyperphosphatemia in chronic kidney disease.
Vervloet MG; van Ballegooijen AJ
Kidney Int; 2018 May; 93(5):1060-1072. PubMed ID: 29580635
[TBL] [Abstract][Full Text] [Related]
18. [Strategies aiming to control hyperphosphatemia in chronic kidney disease].
Ureña Torres PA
Nephrol Ther; 2017 Apr; 13 Suppl 1():S95-S101. PubMed ID: 28577750
[TBL] [Abstract][Full Text] [Related]
19. Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk.
Toussaint ND; Pedagogos E; Tan SJ; Badve SV; Hawley CM; Perkovic V; Elder GJ
Nephrology (Carlton); 2012 Jul; 17(5):433-44. PubMed ID: 22574672
[TBL] [Abstract][Full Text] [Related]
20. Contemporary management of phosphorus retention in chronic kidney disease: a review.
Amiri FS
Clin Exp Nephrol; 2015 Dec; 19(6):985-99. PubMed ID: 26032778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
